Press release
Peptide Based Metabolic Disorders Therapeutics Market Anticipated to Show a Value US$ 8 Bn until 2022
Fact.MR
Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=187
Ongoing research and development activities have maintained their focus on treatments for human ailments. The peptide therapeutics is used to treat various ailments, one such being the metabolic disorders. The global peptide based metabolic disorders therapeutics market is positively impacted by factors such as efficacy, safety, innovations in drug discovery, easy synchronization, stability, etc. Moreover, in addition to these factors, certain economic aspects also fuel the growth of the global peptide based metabolic disorders therapeutics market. The increasing investment in the healthcare industry and in research, the technological advancements, rise in biotech and pharmaceutical companies dealing with peptides. The increase in the metabolic disorder rate has made it imperative to develop new treatments with peptides and this has spurred the adoption of peptide therapeutics in the treatment of metabolic disorders, thereby contributing to the growth of the global peptide based metabolic disorders therapeutics market.
The global peptide based metabolic disorders therapeutics market is anticipated to show a value more than US$ 8 Bn and expected to grow at a robust rate during the period of forecast.
3 Forecast Highlights on Global Peptide Based Metabolic Disorders Therapeutics Market
1. North America expected to grow at the highest CAGR to reflect a growth rate of 10.6% during the period of forecast as well as dominate the global market in terms of market share by revenue, as of 2017. It can be said that this trend would be followed, considering the technological developments, and the higher investments in the healthcare industry that this segment portrays, and retain its dominant position by the end of 2022, at least
2. Asia-Pacific excluding Japan (APEJ) region also anticipated to grow at a similar growth rate as of North America region, yet does not portray high market share by revenue. The market share by revenue of APEJ is less than one third than that of North America region and less than half of the market revenue share of the Europe region
3. Liraglutide segment by drug class is expected to grow at a robust rate during the period of forecast and dominates the market by drug class in terms of market share by revenue as of 2017. However, the growth rate of this segment is comparatively low than that of the other two segments by drug class
Browse Full Report with TOC- https://www.factmr.com/report/187/peptide-based-metabolic-disorders-therapeutics-market
APEJ Shows a Similar Growth Rate
The Asia-Pacific excluding Japan (APEJ) region had shown rapid growth in the past with respect to global peptide based metabolic disorders therapeutics market, and is poised to reflect a higher growth rate, as fast as North America. APEJ will register a CAGR of 10.5% during the forecast period. The main reasons for this kind of growth is the strict government regulations for the upcoming players, higher number of pharmaceutical companies, increased foreign direct investment and development of technologies. Moreover, the government encourages to increase the investment in the healthcare industry to discover and invent new methods & technologies to better the health of the patients and enhance treatment outcomes. Europe region, following APEJ region, also reflects itself as a positive platform for the growth of the global peptide based metabolic disorders therapeutics market.
Hospital Pharmacies Segment Shows Supremacy, Online Pharmacy Shows Growth
The hospital pharmacies segment by distribution channel reflect a higher market share by revenue and a higher growth rate throughout the period of forecast. However, the online pharmacies segment shows even higher growth rate as compared to hospital pharmacies segment, and is expected to register a CAGR of 11.8% during the period of forecast. But the market share of this segment is less; hospital pharmacies segment enjoys a market share more than three times than that of online pharmacies segment. The online pharmacies segment is expected to enjoy a gain in the BPS by the end of 2022. On the other hand, the retail pharmacies segment shows moderate growth rate, yet higher than that of the hospital pharmacies segment and a market share more than double than that of the online pharmacies segment as of 2017.
Competition Tracking
The report also profiles companies that are expected to remain active in the expansion of the global peptide based metabolic disorders therapeutics market through 2022, which include AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., PolyPeptide Group, Novo Nordisk A/S, Merck & Co., Inc., Ipsen S.A, Eli Lilly and Company, CordenPharma International, and Bachem Holding AG.
Request Methodology of the Report- https://www.factmr.com/connectus/sample?flag=RM&rep_id=187
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com
Web: https://www.factmr.com/
follow us in Linkedin: https://www.linkedin.com/company/factmr/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Based Metabolic Disorders Therapeutics Market Anticipated to Show a Value US$ 8 Bn until 2022 here
News-ID: 1071506 • Views: …
More Releases from Fact.MR
Plasma Fractionation Market Projected to Reach US$ 65 Billion by 2032, With 7.3% …
The plasma fractionation market is projected to be valued US$ 32 billion in 2022. Moreover, growth is anticipated to pick up speed at a 7.3% CAGR over the assessment period of 2022-2032 and reach US$ 65 billion. The primary driver of the market's growth is the aging of the global population, which makes people more vulnerable to rare illnesses that call for the usage of blood derivatives.
Furthermore, it is anticipated…
Chemical Pulp Market Predicted to Garner US$ 19.5 Billion by 2033, At CAGR 7.4% …
According to the most recent data from market research and competitive intelligence provider Fact.MR, the global chemical pulp market is projected to grow at a compound annual growth rate (CAGR) of 7.4% between 2023 and 2033, reaching US$ 19.5 billion by the end of 2033.
Large tanks called digesters are used to combine chemicals and wood chips to create chemical pulp. Lignin, which helps hold cellulose fibers together without seriously harming…
Hemodialysis Market to Grow at 4.5% CAGR, Crossing US$ 149.92 Billion by 2033 | …
The hemodialysis market is expected to reach US$ 149.92 billion by 2033, from its estimated US$ 96.54 billion in 2023, according to a recent industry analysis by Fact.MR, a supplier of competitive intelligence and market research.
Dialysis is a process that removes waste products from the blood, like creatinine and urea, which are created when the kidneys don't work properly. For people with chronic renal disorders, dialysis is required. Hemodialysis is…
Agricultural Film Market is forecasted to reach US$ 21 billion with 5.9% CAGR by …
Fact.MR, a market research and competitive intelligence service, states that historically, the use of Agricultural Films grew at a 3.5% CAGR from 2016 to 2020, with the United States, China, India, and Japan holding a sizable portion of the global market. by 2021, the greenhouse film industry is expected to have grown to a valuation of over US$ 10 billion, largely due to price increases in agricultural films.
For More Insights…
More Releases for APEJ
Dimethylolpropionic Acid (DMPA) Market: APEJ to Remain Largest Consuming
Future Market Insights (FMI) delivers key insights on the global dimethylolpropionic acid market in its upcoming report titled “Dimethylolpropionic Acid (DMPA) Market: Global Industry Analysis and Opportunity Assessment 2015–2020”. The global Dimethylolpropionic Acid (DMPA) market is projected to expand at a CAGR of over 8% during the forecast period (2015–2020), largely due to increasing demand for polyurethane dispersions, regarding which FMI offers vital insights in detail in this report.
On the…
Ginger Market: APEJ to Present Attractive Growth Opportunities
The global ginger market is characterized by the presence of a large pool of established players, and therefore the market’s vendor landscape is fragmented and competitive in nature. The players are making use of new flavours in order to attract more customers and introducing new products with added nutrients, notes Transparency Market Research (TMR) in its report on the global ginger market. Some of the players within the market which…
Card Printing Ribbon Market APEJ to Spearhead
According to a new study by Transparency Market Research (TMR), the business landscape in the global card printing ribbon market is highly competitive. Zebra Technologies, Entrust Datacard Corp., IdentiSys Inc., HID Global Corp., Evolis SA, NBS Technologies Inc., AlphaCard, Unicard Systems Pty. Ltd., Dai Nippon Printing Co. Ltd., and Idp Corp. are some of the leading players in this market. They are likely to focus on mergers and acquisitions in…
Rigid Food Containers Market APEJ to Remain Largest
The global rigid food containers market is projected to register a moderate 4 % CAGR throughout the forecast period (2017-2022), according to a new study by Future Market Insights (FMI). The report estimates the global rigid food containers market to surpass revenues worth US$ 80,000 Mn by 2022-end.
Key Takeaways from FMI’s Report on Global Rigid Food Containers Market
Rigid food containers will continue to find the largest applications in ready-to-eat food…
Shrimp Market APEJ to Dominate the Global
Future Market Insights’ new report titled “Shrimp Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” studies the overall performance of the highly competitive global shrimp market for the assessment period of 10 years.
The global shrimp market is anticipated to expand at a significant CAGR over the forecast period and APEJ is likely to dominate the market by grabbing maximum revenue share during the assessed 10 year period.
Revenue from…
Aquafeed Market APEJ to Remain Dominant in Regional
A US$ 50 Bn market, the global aquafeed market has been largely concentrated in the APEJ region for over two decades, owing to a large supply of fresh water in the region and a thriving aquaculture market. While North America will continue to witness significant growth during the forecast period, the MEA market is slated to display great potential in the coming years, owing to a cheap labour force and…
